A large-scale manufacturing method of l -alanyl- l -glutamine used for a component of parenteral nutrition has been studied. The method consisted of a reaction of d -2-chloro- or d -2-bromopropionic acid with thionyl chloride and Schotten−Baumann reaction with l -glutamine followed by ammonolysis reaction. The intermediate d -2-chloropropionyl- l -glutamine was found to be more stable than its bromo analogue. In the ammonolysis reaction, the former intermediate needed a higher reaction temperature, but the by-products produced had little effect on the quality of the final product. The structures of the by-products were conjectured mainly by mass spectrometry and they were removed by anion resin treatment and recrystallization.
No takes yet. Share an insight, caveat, or question.
Sano et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: